We were delighted to meet up with Noel Alpins (NewVision Clinic, Victoria, Australia) again to hear about the PROWL-1 and PROWL-2 studies, and reports the patients most likely to benefit from LASIK vector planning.
1. What were the aims of the PROWL-1 and PROWL-2 studies? (0:04)
2. What were the incidences of glare, starburst and halos in these studies? (2:00)
3. What are the causes of glare and halos? (3:34)
4. How can we reduce the incidence of glare and halos after LASIK? (4:40)
5. Which patients are likely to benefit most from LASIK vector planning and in whom is it contraindicated? (6:06)
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Refractive Surgery
Deepinder K Dhaliwal, AAO 2020 – Myopia Options in a 50-year-old Myope
We were delighted to speak with Deepinder K Dhaliwal (University of Pittsburgh School of Medicine, Pittsburgh, PA, USA) about her refractive surgery panel at AAO 2020, discussing a case of a 50-year-old -8.00D myope, and the issues and recommendations for treatment. Questions Could you give us a brief overview of the case; who were the […]
Dan Z Reinstein, ESCRS 2020 – Lenticule Extraction or Implantation for Hyperopia
Prof. Dan Z Reinstein (London Vision Clinic, London, UK) talked us through his presentation at ESCRS on lenticule extraction or implantation for hyperopia: what will be the future? Questions Could you briefly introduce yourself and the topic you are presenting? (00:07) Could you tell us a little about the history of lenticule extraction and implantation? […]
Noel Alpins, ESCRS 2020 – Treatment of Astigmatism Using Vector Planning Paradigm
It was a pleasure to catch up with Prof. Noel Alpins (Department of Ophthalmology, Melbourne University, Melbourne, Australia), as he discussed the major challenges of refractive surgery in the treatment of astigmatism, and the evidence for the use of Vector Planning in clinical practice. Questions What are the major challenges of refractive surgery in the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!